Speaker:
Title:
Proteomic Analysis of Cartilage Matrix Breakdown and Corticosteroid Effects
Abstract:
Currently there exists no prognostic biomarker to identify the
early stages of osteoarthritis (OA), which complicates the application of
potentially disease-modifying drugs such as the corticosteroid dexamethasone.
Here we utilize a model system of post-traumatic OA using human cartilage
explants to quantify the matrix breakdown of diseased cartilage and determine
the effects of corticosteroids via mass spectrometry. This analysis
identifies novel putative disease biomarkers for early OA and reveals
potential metabolic effects of dexamethasone.